Riskpilot← Back to searchSign inGet full accessALSTAHAUG DYREKLINIKK AS
ASActiveOrg 990016151Sjøbergs Gate 26, 8800 SandnessjøenVeterinary activities · NACE 7500Est. 20063 employees
Revenue 2024
NOK 5,6M
+5% vs 2023
EBITDA margin
-7.5%
-242% vs 2023
Equity ratio
75.5%
Financial strength
Net profit 2024
NOK -351K
-284% vs 2023
| Revenue | NOK 5,6M | +5% |
| EBITDA | NOK -418K | -242% |
| Net profit | NOK -351K | -284% |
| Total assets | NOK 2M | -20% |
| Equity | NOK 1,5M | -19% |
| Employees | 3 | — |
Legal name
ALSTAHAUG DYREKLINIKK AS
Org number
990016151
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
5. juli 2006
Share capital
NOK 105 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Selskapets virksomhet er å drive smådyrklinikk, herunder veterinærtjenester og salg av produkter samt andre tjenester i tilknytning til dette.
Address
Sjøbergs Gate 26, 8800 Sandnessjøen
Phone
+4775041300
Email
post@alstahaug-dyreklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 474 | 4 996 | 4 694 | 5 316 | 5 556 |
| Staff expenses | −472 | −650 | −705 | −634 | −701 |
| EBITDA | 306 | 372 | 484 | 294 | −418 |
| Depreciation & amort. | −43 | −53 | −21 | −62 | −50 |
| EBIT | 262 | 319 | 463 | 232 | −468 |
| Net financials | −0 | −0 | 7 | 12 | 18 |
| Profit before tax | 262 | 319 | 470 | 245 | −450 |
| Tax | 60 | 71 | 104 | 54 | −99 |
| Net profit | 203 | 248 | 366 | 191 | −351 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 918 | 2 222 | 2 499 | 2 492 | 1 983 |
| Equity | 1 311 | 1 476 | 1 721 | 1 848 | 1 497 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 607 | 745 | 778 | 644 | 486 |
| Total debt | 607 | 745 | 778 | 644 | 486 |
EBITDA margin
-7.5%
This company
15.8%
Market median
-147% vs market
20202024
Equity ratio
75.5%
This company
38.2%
Market median
+98% vs market
20202024
Return on equity
-23.4%
This company
18.4%
Market median
-227% vs market
20202024
Net profit margin
-6.3%
This company
8.1%
Market median
-178% vs market
20202024
Asset turnover
2.80×
This company
1.12×
Market median
+150% vs market
20202024
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LA Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2017 | |
| Chairman | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 66.67% | 66.67% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Porsengåsen As
ALSTAHAUG DYREKLINIKK AS Board members of ALSTAHAUG DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lise Aanensen | Chief Executive Officer | 0 companies |
| Anne Marte Svendsen | Board of Directors | 0 companies |
| Odd Magne Karlsen | Chairman | 0 companies |